Thrombosis with thrombocytopenia cases reported following ChAdOx1 nCov-19 vaccination (AstraZeneca).</p
Cerebral venous thrombosis (CVT) events have been reported after vaccination with adenoviral COVID-1...
Schlutz et al. published data of five patients with venous thrombosis and thrombocytopenia about 7 ...
Here we are elaborating the cases of a rare reaction of COVID-19 vaccine based on adenoviral (ChAdOx...
Abstract Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic thrombocyt...
Vaccination with ChAdOx1 nCoV-19 can result in vaccine-induced immune thrombotic thrombocytopenia (V...
We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 1...
This case series reports 40 patients (median age, 41 years [interquartile range (IQR) 32- 52, 22 men...
BACKGROUND The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccinatio...
BACKGROUND The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccina...
A 50-year-old Indian woman presented with acute dysphasia, left upper limb numbness and thrombocytop...
Background: ChAdOx1 nCov-19 vaccine is a viral vector-based vaccine with desirable protection (about...
The ChAdOx1 nCoV-19 adenoviral vector-based vaccine was the first to be approved against COVID-19 in...
BackgroundThe mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccination...
OBJECTIVE: To perform a systematic review of case reports or case series regarding thrombosis with t...
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the ...
Cerebral venous thrombosis (CVT) events have been reported after vaccination with adenoviral COVID-1...
Schlutz et al. published data of five patients with venous thrombosis and thrombocytopenia about 7 ...
Here we are elaborating the cases of a rare reaction of COVID-19 vaccine based on adenoviral (ChAdOx...
Abstract Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic thrombocyt...
Vaccination with ChAdOx1 nCoV-19 can result in vaccine-induced immune thrombotic thrombocytopenia (V...
We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 1...
This case series reports 40 patients (median age, 41 years [interquartile range (IQR) 32- 52, 22 men...
BACKGROUND The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccinatio...
BACKGROUND The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccina...
A 50-year-old Indian woman presented with acute dysphasia, left upper limb numbness and thrombocytop...
Background: ChAdOx1 nCov-19 vaccine is a viral vector-based vaccine with desirable protection (about...
The ChAdOx1 nCoV-19 adenoviral vector-based vaccine was the first to be approved against COVID-19 in...
BackgroundThe mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccination...
OBJECTIVE: To perform a systematic review of case reports or case series regarding thrombosis with t...
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the ...
Cerebral venous thrombosis (CVT) events have been reported after vaccination with adenoviral COVID-1...
Schlutz et al. published data of five patients with venous thrombosis and thrombocytopenia about 7 ...
Here we are elaborating the cases of a rare reaction of COVID-19 vaccine based on adenoviral (ChAdOx...